POST Online Media Lite Edition


DefiniGEN appoints Chris Kirton as CEO

Christian Fernsby |
Cambridge, United Kingdom - DefiniGEN, a provider of human cells to the drug discovery sector, announces the appointment of Chris Kirton as chief executive officer.

Article continues below

Dr. Kirton has more than 16 years of operational experience and joined DefiniGEN as Chief Operating Officer in June 2020.

Dr. Kirton began his operational management career by establishing and growing the Cell Biology and Immunology business unit at a global CRO from a small local team to an international business, offering a full range of GxP services with multi-million-pound revenues.

He then went on to collaborate with Ludovic Vallier to establish the world’s largest stem cell core facility at the Wellcome Trust Sanger Institute, which delivered the HiPSCi iPSC banking project.

 LATEST MOVES FROM United Kingdom 

Aston Martin appoints Amedeo Felisa as CEO
Titon Holdings appoints Alexandra French as chief executive officer
Pepco Group appoints Trevor Masters as permanent CEO
Victrex appoints Ian Melling as CFO
10x Banking appoints Virginia Gambale as non-executive director